Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

DMPHF

Dermapharm Holding SE

USD

Set alert

Price alert · DMPHF

All alert types
47.69 USD 0.00 0.00%
As of Oct 29, 2026
47.69 Day range 47.69
39.56 52-week range 53.00
YTD
+20.55%
1 year
+20.55%
Open
47.69
Prev close
47.69
Mkt cap
2.36B
Vol
100
Avg vol
0
EPS
3.23
P/E
14.76
More statistics
Low
47.69
High
47.69

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for DMPHF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.06 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 13.7×
FY 2016: 26.3×FY 2017: 22.8×FY 2018: 26.4×FY 2019: 26.6×FY 2020: 22.0×FY 2021: 9.6×FY 2022: 16.0×FY 2023: 33.3×FY 2024: 19.5×FY 2025: 13.7×
FY 2016 5y median 16.0× FY 2025
P/S 1.6×
FY 2016: 4.6×FY 2017: 3.8×FY 2018: 3.5×FY 2019: 2.9×FY 2020: 2.4×FY 2021: 2.1×FY 2022: 2.1×FY 2023: 1.8×FY 2024: 1.9×FY 2025: 1.6×
FY 2016 5y median 1.9× FY 2025
P/B 2.6×
FY 2016: 35.6×FY 2017: 24.1×FY 2018: 7.9×FY 2019: 7.4×FY 2020: 5.8×FY 2021: 4.1×FY 2022: 4.0×FY 2023: 3.9×FY 2024: 3.7×FY 2025: 2.6×
FY 2016 5y median 3.9× FY 2025
P/FCF 13.0×
FY 2016: 34.3×FY 2017: 148×FY 2018: 14.9×FY 2019: 37.8×FY 2020: 20.8×FY 2021: 10.7×FY 2022: 8.6×FY 2023: 11.7×FY 2024: 13.6×FY 2025: 13.0×
FY 2016 5y median 11.7× FY 2025
EV/EBITDA 8.5×
FY 2016: 20.7×FY 2017: 18.1×FY 2018: 14.8×FY 2019: 14.8×FY 2020: 13.0×FY 2021: 6.8×FY 2022: 7.8×FY 2023: 11.4×FY 2024: 9.7×FY 2025: 8.5×
FY 2016 5y median 8.5× FY 2025
EV/Sales 2.3×
FY 2016: 4.9×FY 2017: 4.3×FY 2018: 3.6×FY 2019: 3.6×FY 2020: 3.0×FY 2021: 2.6×FY 2022: 2.5×FY 2023: 2.6×FY 2024: 2.6×FY 2025: 2.3×
FY 2016 5y median 2.6× FY 2025
FCF Yield 7.7%
FY 2016: 2.9%FY 2017: 0.7%FY 2018: 6.7%FY 2019: 2.6%FY 2020: 4.8%FY 2021: 9.4%FY 2022: 11.6%FY 2023: 8.6%FY 2024: 7.3%FY 2025: 7.7%
FY 2016 5y median 8.6% FY 2025

Profitability

Gross Margin 33.6%
FY 2016: 45.2%FY 2017: 47.4%FY 2018: 52.4%FY 2019: 54.7%FY 2020: 58.4%FY 2021: 65.8%FY 2022: 64.5%FY 2023: 61.2%FY 2024: 65.0%FY 2025: 33.6%
FY 2016 5y median 64.5% FY 2025
Operating Margin 19.0%
FY 2016: 19.5%FY 2017: 19.7%FY 2018: 18.8%FY 2019: 17.1%FY 2020: 17.2%FY 2021: 31.7%FY 2022: 23.8%FY 2023: 15.9%FY 2024: 18.4%FY 2025: 19.0%
FY 2016 5y median 19.0% FY 2025
Net Margin 11.4%
FY 2016: 3.8%FY 2017: 16.6%FY 2018: 13.2%FY 2019: 11.0%FY 2020: 10.8%FY 2021: 22.2%FY 2022: 13.1%FY 2023: 5.4%FY 2024: 9.6%FY 2025: 11.4%
FY 2016 5y median 11.4% FY 2025
ROE 19.1%
FY 2016: 29.6%FY 2017: 105.5%FY 2018: 29.8%FY 2019: 27.7%FY 2020: 26.7%FY 2021: 42.1%FY 2022: 25.3%FY 2023: 11.6%FY 2024: 18.8%FY 2025: 19.1%
FY 2016 5y median 19.1% FY 2025
ROIC 8.0%
FY 2016: 30.4%FY 2017: 22.2%FY 2018: 12.3%FY 2019: 8.9%FY 2020: 8.4%FY 2021: 16.9%FY 2022: 12.5%FY 2023: 5.5%FY 2024: 7.6%FY 2025: 8.0%
FY 2016 5y median 8.0% FY 2025
ROA 6.0%
FY 2016: 5.4%FY 2017: 18.7%FY 2018: 10.7%FY 2019: 7.4%FY 2020: 7.0%FY 2021: 14.9%FY 2022: 9.5%FY 2023: 2.9%FY 2024: 5.5%FY 2025: 6.0%
FY 2016 5y median 6.0% FY 2025

Growth (YoY)

Revenue -1.4%
FY 2016: 15.5%FY 2017: 5.1%FY 2018: 22.5%FY 2019: 22.4%FY 2020: 13.3%FY 2021: 18.8%FY 2022: 8.7%FY 2023: 12.3%FY 2024: 2.6%FY 2025: -1.4%
FY 2016 FY 2025
Operating Income 2.2%
FY 2016: 42.8%FY 2017: 6.1%FY 2018: 16.7%FY 2019: 11.2%FY 2020: 14.5%FY 2021: 118.1%FY 2022: -18.4%FY 2023: -24.9%FY 2024: 18.6%FY 2025: 2.2%
FY 2016 FY 2025
EPS (diluted) 16.6%
FY 2016: 495.8%FY 2017: 9.1%FY 2018: -9.6%FY 2019: 1.4%FY 2020: 11.2%FY 2021: 144.7%FY 2022: -36.0%FY 2023: -53.4%FY 2024: 81.9%FY 2025: 16.6%
FY 2016 FY 2025
Free Cash Flow -14.6%
FY 2016: 132.0%FY 2017: -79.6%FY 2018: 1007.7%FY 2019: -59.3%FY 2020: 66.7%FY 2021: 109.5%FY 2022: 31.9%FY 2023: -28.7%FY 2024: -8.3%FY 2025: -14.6%
FY 2016 FY 2025

Financial Health

Current Ratio 2.0×
FY 2016: 1.4×FY 2017: 2.4×FY 2018: 2.5×FY 2019: 3.4×FY 2020: 3.0×FY 2021: 3.3×FY 2022: 2.5×FY 2023: 1.6×FY 2024: 1.8×FY 2025: 2.0×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 1.1×
FY 2016: 0.6×FY 2017: 1.4×FY 2018: 1.7×FY 2019: 1.8×FY 2020: 1.5×FY 2021: 1.8×FY 2022: 1.3×FY 2023: 0.8×FY 2024: 0.8×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 1.5×
FY 2016: 2.9×FY 2017: 3.5×FY 2018: 1.2×FY 2019: 2.0×FY 2020: 1.9×FY 2021: 1.2×FY 2022: 1.0×FY 2023: 2.0×FY 2024: 1.6×FY 2025: 1.5×
FY 2016 5y median 1.5× FY 2025
Net Debt / EBITDA 2.7×
FY 2016: 1.5×FY 2017: 2.2×FY 2018: 0.7×FY 2019: 2.6×FY 2020: 2.7×FY 2021: 1.2×FY 2022: 1.1×FY 2023: 3.5×FY 2024: 2.7×FY 2025: 2.7×
FY 2016 5y median 2.7× FY 2025
Interest Coverage 4.2×
FY 2016: 9.3×FY 2017: 12.8×FY 2018: 17.8×FY 2019: 11.9×FY 2020: 14.6×FY 2021: 33.8×FY 2022: 16.4×FY 2023: 3.3×FY 2024: 3.7×FY 2025: 4.2×
FY 2016 5y median 4.2× FY 2025

Dividends

Dividend Yield 2.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 2.0%FY 2020: 2.3%FY 2021: 2.3%FY 2022: 5.4%FY 2023: 2.7%FY 2024: 2.1%FY 2025: 2.7%
FY 2016 5y median 2.7% FY 2025
Payout Ratio 36.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 53.7%FY 2020: 50.2%FY 2021: 22.6%FY 2022: 87.0%FY 2023: 90.6%FY 2024: 41.6%FY 2025: 36.6%
FY 2016 5y median 41.6% FY 2025

Annual · latest fiscal year ends 2025-12-31